Skip to content
MEO NextGenDeveloper StudioDEV
  1. Dashboard
  2. Questions
  3. SBA
  4. Q711
SBA

SBA — Single Best Answer · Review

Question 711

Obstetric infection → Viral

NextGen Workflow Status Needs Review
SQL status generated
Destination Site
Type SSBA
UUID e4e9bf44-af0a-49d1-88ec-547dcc4b44c5

Classification

Speciality
Obstetrics and Gynaecology
Group
Clinical
Title
Obstetric infection
Topic
Viral
Subtopic 1
Chickenpox
Subtopic 2
Pathogenesis
Subtopic 3
Prevention
Question Type
SBA

Question

SSBA
Question Header
Timing of antiviral post-exposure prophylaxis
Question Stem
A non-immune pregnant woman has had significant exposure to chickenpox. Oral aciclovir is selected for post-exposure prophylaxis. During which period should the antiviral prophylaxis be given?

Options

A Days 1–5 after exposure
B Days 7–14 after exposure
C Days 3–7 after exposure
D Days 14–21 after exposure
E Only after a rash develops

Explanation

Oral aciclovir or valaciclovir used as post-exposure prophylaxis should be given from day 7 to day 14 following exposure. This timing distinguishes prophylaxis from treatment of established chickenpox. If a rash develops, the woman should be managed according to the recommendations for clinical maternal infection.

Option Validity

A) this is earlier than the recommended PEP interval.

C) prophylaxis starts from day 7 after exposure.

D) this delays initiation beyond the recommended starting point.

E) development of a rash represents established infection rather than the indication to start PEP.

Further Reading

RCOG Green-top Guideline No. 13, Chickenpox in Pregnancy, section 4.3.

Source & metrics

Authored Difficulty
3.00
Evaluation Score
9.70
Destination
Site
Source
RCOG Green-top Guideline No. 13: Chickenpox in Pregnancy (2015, minor update 2024)
Source Section
Section 4.3
Source Locator
Entire guideline
Updated
2026-10-06 01:57:35
Difficulty Factor
Not available yet
Attended Users
No candidate-attempt data yet
Review Question